Bill

Bill > LD675


ME LD675

ME LD675
An Act to Protect Consumers by Increasing Transparency and Accountability in the Pharmaceutical Industry


summary

Introduced
02/20/2025
In Committee
02/20/2025
Crossed Over
Passed
Dead
05/21/2025

Introduced Session

132nd Legislature

Bill Summary

This bill is a concept draft pursuant to Joint Rule 208. This bill proposes to increase transparency and accountability in the pharmaceutical industry to protect consumers of this State.

AI Summary

This bill is a concept draft, which means it outlines a broad idea for potential legislation without providing specific detailed language. The bill aims to increase transparency and accountability in the pharmaceutical industry with the goal of protecting consumers in the state of Maine. While the provided XML document does not contain specific provisions, the government-provided summary suggests the bill would focus on creating mechanisms to make pharmaceutical industry practices more open and consumer-friendly. As a concept draft, it represents an initial step in the legislative process where lawmakers are signaling their intent to develop more comprehensive legislation addressing potential issues in pharmaceutical pricing, marketing, or other industry practices that might negatively impact consumers. Further development of the bill would be needed to define exact requirements, enforcement mechanisms, and specific protections for consumers.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Pursuant to Joint Rule 310.3 Placed in Legislative Files (DEAD) (on 05/21/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...